This week, we're turning our attention to Health and Wellness startups - those innovators who use technology to help us live better, longer lives.

Pharmaceutical giant AstraZeneca and BenevolentAI have completed a long-term deal to use their technology for the discovery and development of treatments for chronic kidney disease (CKD) and idiopathic pulmonary fibrosis (IPF).

Subscribe to RSS - benevolentai